CIP
Chartwell Investment Partners Portfolio holdings
AUM
$2.91B
1-Year Return
40.48%
This Quarter Return
+8.86%
1 Year Return
+40.48%
3 Year Return
+57.19%
5 Year Return
+149.04%
10 Year Return
+395.35%
AUM
$3.03B
AUM Growth
+$37.3M
(+1.2%)
Cap. Flow
-$168M
Cap. Flow
% of AUM
-5.55%
Top 10 Holdings %
Top 10 Hldgs %
10.89%
Holding
446
New
42
Increased
142
Reduced
204
Closed
38
Top Buys
| 1 |
Moog
MOG.A
|
$16.3M |
| 2 |
Bristol-Myers Squibb
BMY
|
$15.2M |
| 3 |
Truist Financial
TFC
|
$13.5M |
| 4 |
ConocoPhillips
COP
|
$8.3M |
| 5 |
Citigroup
C
|
$7.66M |
Top Sells
| 1 |
Pfizer
PFE
|
$19.7M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
$12.3M |
| 3 |
Prudential Financial
PRU
|
$10.4M |
| 4 |
MANT
Mantech International Corp
MANT
|
$8.95M |
| 5 |
ESCO Technologies
ESE
|
$8.82M |
Sector Composition
| 1 | Financials | 18.48% |
| 2 | Technology | 14.71% |
| 3 | Industrials | 14.65% |
| 4 | Consumer Discretionary | 11.24% |
| 5 | Healthcare | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVBG
351
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $1.05M | 0.03% |
+13,420
| New | +$1.05M |
|
352
HubSpot
HUBS
$24.5B
| $997K | 0.03% |
6,290
-7
| -0.1% | -$1.11K |
|
353
Sarepta Therapeutics
SRPT
$1.93B
| $978K | 0.03% |
7,576
-834
| -10% | -$108K |
|
|
BPMC
354
DELISTED
Blueprint Medicines
BPMC
| $962K | 0.03% |
12,004
-11,771
| -50% | -$943K |
|
355
KB Home
KBH
$4.49B
| $934K | 0.03% |
+27,262
| New | +$934K |
|
356
Lithia Motors
LAD
$8.72B
| $932K | 0.03% |
+6,341
| New | +$932K |
|
357
Webster Financial
WBS
$10.5B
| $926K | 0.03% |
17,346
-17,261
| -50% | -$921K |
|
358
Coherus Oncology, Inc. Common Stock
CHRS
$152M
| $924K | 0.03% |
51,319
-104,762
| -67% | -$1.89M |
|
|
LHCG
359
DELISTED
LHC Group LLC
LHCG
| $915K | 0.03% |
6,642
-6,507
| -49% | -$896K |
|
360
RBC Bearings
RBC
$12.3B
| $892K | 0.03% |
5,633
-5,524
| -50% | -$875K |
|
|
MYOK
361
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $839K | 0.03% |
+11,516
| New | +$839K |
|
|
CCXI
362
DELISTED
ChemoCentryx, Inc.
CCXI
| $827K | 0.03% |
+20,916
| New | +$827K |
|
363
PagerDuty
PD
$1.55B
| $820K | 0.03% |
+35,054
| New | +$820K |
|
364
Stryker
SYK
$151B
| $814K | 0.03% |
+3,879
| New | +$814K |
|
365
BlackBerry
BB
$2.26B
| $809K | 0.03% |
125,943
-2,260
| -2% | -$14.5K |
|
|
SILK
366
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $758K | 0.03% |
+18,760
| New | +$758K |
|
367
Vericel Corp
VCEL
$1.7B
| $742K | 0.02% |
42,658
-41,829
| -50% | -$728K |
|
368
Ares Management
ARES
$39.5B
| $738K | 0.02% |
+20,683
| New | +$738K |
|
369
IQVIA
IQV
$31.3B
| $736K | 0.02% |
4,765
| – | – |
|
370
Neurocrine Biosciences
NBIX
$13.9B
| $690K | 0.02% |
6,418
| – | – |
|
371
Fiserv
FI
$74B
| $646K | 0.02% |
+5,589
| New | +$646K |
|
372
Castle Biosciences
CSTL
$670M
| $645K | 0.02% |
18,755
-18,400
| -50% | -$633K |
|
|
SAGE
373
DELISTED
Sage Therapeutics
SAGE
| $643K | 0.02% |
8,908
+4,045
| +83% | +$292K |
|
374
TransDigm Group
TDG
$72.2B
| $626K | 0.02% |
1,118
-150
| -12% | -$84K |
|
375
Alcoa
AA
$8.1B
| $609K | 0.02% |
28,323
-33,744
| -54% | -$726K |
|